Ngm Biopharmaceuticals Inc

Jasper Ridge Partners, L.P.

Report date

3/31/2024

Quarter

2024 Q1

Filed

5/15/2024

Shares

19,250

Value ($000)

31

Weight

0.0%

2019 Q4 - 2024 Q1 (18 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2024 Q1	5/15/2024	31	0.0%	19,250	3/31/2024
2023 Q4	2/14/2024	17	0.0%	19,250	12/31/2023
2023 Q3	11/14/2023	325	0.0%	303,492	9/30/2023
2023 Q2	8/14/2023	902	0.0%	348,250	6/30/2023
2023 Q1	5/15/2023	1,421	0.1%	348,250	3/31/2023
2022 Q4	2/15/2023	1,748	0.1%	348,250	12/31/2022
2022 Q3	11/14/2022	4,169	0.3%	318,750	9/30/2022
2022 Q2	8/15/2022	4,086	0.2%	318,750	6/30/2022
2022 Q1	8/15/2022	4,747	0.2%	311,250	3/31/2022
2021 Q4	8/12/2022	5,495	0.2%	310,250	12/31/2021
2021 Q3	8/12/2022	6,521	0.3%	310,250	9/30/2021
2021 Q2	8/12/2022	6,118	0.3%	310,250	6/30/2021
2021 Q1	8/12/2022	8,975	0.4%	308,750	3/31/2021
2020 Q4	8/12/2022	9,354	0.4%	308,750	12/31/2020
2020 Q3	8/12/2022	4,912	0.3%	308,750	9/30/2020
2020 Q2	8/12/2022	6,095	0.4%	308,750	6/30/2020
2020 Q1	8/12/2022	3,807	0.3%	308,750	3/31/2020
2019 Q4	2/13/2020	5,676	0.4%	307,000	12/31/2019